ProPSA and diagnostic biopsy tissue DNA content combination improves accuracy to predict need for prostate cancer treatment among men enrolled in an active surveillance program.


No abstract available.

  • Carter HB
  • Epstein JI
  • Isharwal S
  • Landis P
  • Makarov DV
  • Marlow C
  • Partin AW
  • Sokoll LJ
  • Veltri RW
PubMed ID
Appears In